Donald M. Hilligoss - Concepedia

Author

Donald M. Hilligoss

Pfizer (United States)

Also Known As

D Hilligoss, D M Hilligoss, DONALD M. HILLIGOSS, Donald Hilligoss, Donald M Hilligoss, Donald M. Hilligoss

Publications

811

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Millard Fillmore Suburban Hospital The Ohio State University University of Minnesota Women & Children's Hospital of Buffalo

About

Donald M. Hilligoss is an author at Pfizer (United States) specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	514
2	Health Sciences	1	1	64
3	Biochemistry	1	1	64
4	Gastroenterology	1	1	167
5	Metabolism	1	1	64

Donald M. Hilligoss

Publications

804

Citations

H-Index

Page 1

	Year	Citations
Increased Gastric pH and the Bioavailability of Fluconazole and Ketoconazole Robert A. Blum, David T. D'Andrea, Becky M. Florentino, Annals of Internal Medicine Gastric PhAntifungal AgentMedicineAntifungal AgentsInformed Consent	1991	167
Effect of fluconazole on the disposition of phenytoin Robert A. Blum, J WILTON, Donald M. Hilligoss, Clinical Pharmacology & Therapeutics	1991	119
INTERACTION BETWEEN CYCLOSPORINE AND FLUCONAZOLE IN RENAL ALLOGRAFT RECIPIENTS Daniel M. Canafax, Nina M. Graves, Donald M. Hilligoss, Transplantation Kidney TransplantFluconazole PatientsMedicineKidney TransplantationChronic Kidney Disease	1991	107
Azithromycin and terfenadine: Lack of drug interaction* Stuart Harris, Donald M. Hilligoss, Philip M. Colangelo, Clinical Pharmacology & Therapeutics Double-blind Placebo-controlled StudyPharmaceutical SciencePharmacological StudyPharmacodynamicsPharmacology	1995	69
Induction of Fluconazole Metabolism by Rifampin: <i>In Vivo</i> Study in Humans Glen Apseloff, Donald M. Hilligoss, Mark Gardner, The Journal of Clinical Pharmacology PharmacotherapyAntimicrobial ChemotherapyExperimental PharmacologyPharmacokineticsTranslational Pharmacology	1991	64
Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension Milap C. Nahata, Katalin Korányi, S D Gadgil, Antimicrobial Agents and Chemotherapy Oral AdministrationPharmacotherapyAntimicrobial ChemotherapyAdverse EffectsDrug Monitoring	1993	55
Interaction of chloramphenicol with phenytoin and phenobarbital; Case report Jeffrey R. Koup, Milo Gibaldi, Patrick J. McNamara, Clinical Pharmacology & Therapeutics	1978	52
Sequential studies on the role of mitoxantrone, high-dose cytarabine, and recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of refractory non-Hodgkin's lymphoma. Jeffrey D. Lazar, Donald M. Hilligoss PubMed	1990	51
Factors Affecting Theophylline Pharmacokinetics in PrematureInfants with Apnea Donald M. Hilligoss, William Jusko, Jeffrey R. Koup, Developmental Pharmacology and Therapeutics	1980	36
Two-compartment gentamicin pharmacokinetics in premature neonates: A comparison to adults with decreased glomerular filtration rates David B. Haughey, Donald M. Hilligoss, Armando Grassi, The Journal of Pediatrics Renal FunctionNeonatologyMedicinePremature NeonatesChronic Kidney Disease	1980	35

Page 1